Physician profile
Richard Byrd
NPI 1437199155
$2,651.15
in general payments reported to CMS, 2019-2025
26 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $244 · 2021: $243 · 2022: $150 · 2023: $693 · 2024: $629 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,761.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $437.49 | 2020-2024 | Seprafilm |
| Takeda Pharmaceuticals U.S.A., INC. | $287.80 | 2020-2025 | Gattex, Entyvio |
| Kerecis Limited | $284.08 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Medtronic, INC. | $204.04 | 2022-2025 | Interstim |
| Pacira Pharmaceuticals Incorporated | $170.38 | 2021-2025 | Exparel |
| Braintree Laboratories, INC. | $150.64 | 2019-2025 | Sutab, Suflave |
| Convatec INC. | $144.46 | 2022-2023 | |
| Acera Surgical, INC. | $132.10 | 2025 | Restrata Wound Matrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.19 | 2019-2020 | |
| Davol INC. | $98.01 | 2024-2025 | Arista Ah Flexitip, Phasix Mesh |
| La Jolla Pharmaceutical Company | $97.30 | 2023 | Xerava |
| Merck Sharp & Dohme LLC | $95.32 | 2019-2024 | Dificid |
| Innovation Technologies INC | $66.07 | 2024-2025 | Irrisept |
| Ethicon US, LLC | $64.08 | 2019-2023 | Enseal, Surgicel Nu-Knit, Monocryl |
| Ferring Pharmaceuticals INC. | $55.22 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $53.02 | 2019 | |
| Solventum Corporation | $29.77 | 2024 | V.A.C. Veraflo, Prevena |
| Lsi Solutions INC | $29.34 | 2021 | |
| Sanara Medtech INC. | $27.98 | 2023 | Celleraterx |
| Thd America, INC. | $22.81 | 2025 | |
| Heron Therapeutics, INC. | $21.49 | 2025 | Zynrelef |
| Shire North American Group INC | $17.79 | 2019 | |
| Siemens Medical Solutions USA, INC. | $16.49 | 2024 | Magnetom Altea |
| Axonics, INC. | $14.64 | 2023 | Bulkamid |
| Tetraphase Pharmaceuticals, INC. | $14.57 | 2020 | |
| Tela Bio, INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.